The rise of copyright’s blockbuster initially sparked a boom for pharma, however recent changes present a complicated scenario for shareholders. Generic alternatives are eroding revenue, and ongoing legal battles add https://aadamtdky149728.blogzet.com/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-bet-56231758